Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;19(5):1752-1763.
doi: 10.1002/alz.12802. Epub 2022 Oct 12.

Pre-diagnostic cognitive and functional impairment in multiple sporadic neurodegenerative diseases

Nol Swaddiwudhipong  1   2 , David J Whiteside  1   2 , Frank H Hezemans  1   3 , Duncan Street  1 , James B Rowe  1   2   3 , Timothy Rittman  1   2
Affiliations

Pre-diagnostic cognitive and functional impairment in multiple sporadic neurodegenerative diseases

Nol Swaddiwudhipong et al. Alzheimers Dement. 2023 May.

Abstract

Introduction: The pathophysiological processes of neurodegenerative diseases begin years before diagnosis. However, pre-diagnostic changes in cognition and physical function are poorly understood, especially in sporadic neurodegenerative disease.

Methods: UK Biobank data were extracted. Cognitive and functional measures in individuals who subsequently developed Alzheimer's disease (AD), Parkinson disease, frontotemporal dementia, progressive supranuclear palsy, dementia with Lewy bodies, or multiple system atrophy were compared against individuals without neurodegenerative diagnoses. The same measures were regressed against time to diagnosis, after adjusting for the effects of age.

Results: There was evidence for pre-diagnostic cognitive impairment and decline with time, particularly in AD. Pre-diagnostic functional impairment and decline were observed in multiple diseases.

Discussion: The scale and longitudinal follow-up of UK Biobank participants provides evidence for cognitive and functional decline years before symptoms become obvious in multiple neurodegenerative diseases. Identifying pre-diagnostic functional and cognitive changes could improve selection for preventive and early disease-modifying treatment trials.

Keywords: Alzheimer's disease; Parkinson disease; UK Biobank; cognition; dementia; dementia with Lewy bodies; frontotemporal dementia; multiple system atrophy; neurodegenerative disease; physical function; pre-diagnostic; progressive supranuclear palsy; sporadic.

PubMed Disclaimer

References

REFERENCES

    1. Cummings J, Lee G, Zhong K, Fonseca J, Taghva K. Alzheimer's disease drug development pipeline: 2021. Alzheimer's & dementia. Trans Res Clin Interventions. 2021;7(1):e12179.
    1. Elmaleh DR, Farlow MR, Conti PS, Tompkins RG, Kundakovic L, Tanzi RE. Developing effective Alzheimer's disease therapies: clinical experience and future directions. J Alzheimer's Dis. 2019;71(3):715-732.
    1. Aisen PS, Vellas B, Hampel H. Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease. Nat Rev Drug Discovery. 2013;12(4):324-324.
    1. GENFI - The Genetic Frontotemporal Initiative. Accessed Mar 26, 2022. https://www.genfi.org/
    1. Rohrer JD, Nicholas JM, Cash DM, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the genetic frontotemporal dementia initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol. 2015;14:253-262.

Publication types

MeSH terms

LinkOut - more resources